Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Supplemental disclosure for statement of cash flows

Supplemental disclosure for statement of cash flows	3 Months Ended
Oct. 31, 2013
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	Note 3 - Supplemental disclosure for statement of cash flows For the three months ended October 31, 2013 and 2012, income taxes paid by the Company approximated $5 and $21, respectively. For the three months ended October 31, 2013 and 2012, interest paid by the Company approximated $65 and $9, respectively. For the three months ended October 31, 2013 and 2012, the Company financed $115 and $0, respectively, in machinery and transportation equipment under installment loans. For the three months ended October 31, 2013 and 2012, the Company entered into a capital lease for machinery and equipment with a cost basis of $0 and $768 respectively.

Supplemental disclosure for statement of cash flows

3 Months Ended

Oct. 31, 2013

Supplemental Cash Flow Elements [Abstract]

Cash Flow, Supplemental Disclosures [Text Block]

Note 3 - Supplemental disclosure for statement of cash flows

For the three months ended October 31, 2013 and 2012, income taxes paid by the Company approximated $5 and $21, respectively.

For the three months ended October 31, 2013 and 2012, interest paid by the Company approximated $65 and $9, respectively.

For the three months ended October 31, 2013 and 2012, the Company financed $115 and $0, respectively, in machinery and transportation equipment under installment loans.

For the three months ended October 31, 2013 and 2012, the Company entered into a capital lease for machinery and equipment with a cost basis of $0 and $768 respectively.